Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Marjolein van Ballegooijen"'
Autor:
Megan Smith, Jane J. Kim, Shalini L Kulasingam, Emily A. Burger, James Killen, Marjolein van Ballegooijen, Catherine Regan, Kate T. Simms, Inge M.C.M. de Kok, Susan Yuill, Karen Canfell
Publikováno v:
Gynecol Oncol
Gynecologic Oncology, 158(3), 710-718. Academic Press
Gynecologic Oncology, 158(3), 710-718. Academic Press
Background SEER-reported cervical cancer incidence rates reflect the total female population including women no longer at risk due to hysterectomy. Hysterectomy rates have been declining in the United States as alternative treatments have become avai
Autor:
Harry J. de Koning, Monique E. van Leerdam, Evelien Dekker, Christian Ramakers, Iris Lansdorp-Vogelaar, Miriam P. van der Meulen, Harriët van Veldhuizen, Anneke J van Vuuren, Marjolein van Ballegooijen, Folkert J. van Kemenade, Marc H M Thelen, Johannes M.G. Bonfrer, Maaike Buskermolen, Maarten Thomeer, Esther Toes-Zoutendijk, Marie-Louise F. van Velthuysen, Manon C.W. Spaander, Ernst J. Kuipers
Publikováno v:
Clinical Chemistry, 65(3), 419-426. American Association for Clinical Chemistry Inc.
Clinical chemistry, 65(3), 419-426. American Association for Clinical Chemistry Inc.
Clinical chemistry, 65(3), 419-426. American Association for Clinical Chemistry Inc.
BACKGROUND Quality assessment is crucial for consistent program performance of colorectal cancer (CRC) screening programs using fecal immunochemical test for hemoglobin (FIT). However, literature on the consistency of FIT performance in laboratory me
Autor:
Clare A. Aitken, Steffie K. Naber, Erik E.L. Jansen, Inge M.C.M. de Kok, Marjolein van Ballegooijen, Harry J. de Koning
Publikováno v:
BJOG: An International Journal of Obstetrics & Gynaecology
BJOG: An International Journal of Obstetrics and Gynaecology, 128(3), 573-582. Wiley-Blackwell Publishing Ltd
BJOG: An International Journal of Obstetrics and Gynaecology, 128(3), 573-582. Wiley-Blackwell Publishing Ltd
Objective: We aim to compare the cost-effectiveness of the old cytology programme with the new high-risk human papillomavirus (hrHPV) screening programme, using performance indicators from the new Dutch hrHPV screening programme. Design: Model-based
Autor:
Christian Ramakers, Marieke A.M. Frasa, Annemieke W.J. Opstal-van Winden, Gerrit A. Meijer, Ernst J. Kuipers, W.M.U. Van Grevenstein, Tj. Wiersma, Iris Lansdorp-Vogelaar, Harry J. de Koning, Geraldine R. Vink, Esther Toes-Zoutendijk, Evelien Dekker, J.A. Otte, Iris D. Nagtegaal, A. van der Beek, J. van Bergeijk, Marie-Louise F. van Velthuysen, L.H.J. Jacobs, E. J. R. de Graaf, Ad A.M. Masclee, Marloes A. G. Elferink, Folkert J. van Kemenade, Manon C.W. Spaander, Arthur I. Kooyker, Marjolein van Ballegooijen, Harriët van Veldhuizen, Monique E. van Leerdam, Jaap Stoker, Maarten Thomeer, Anneke J van Vuuren, Maaike Buskermolen
Publikováno v:
Clinical Gastroenterology and Hepatology, 18(7), 1493-1500. W.B. Saunders
Clinical gastroenterology and hepatology, 18(7), 1493-1500. W.B. Saunders Ltd
Clinical Gastroenterology and Hepatology, 18, 1493-1500
Clinical Gastroenterology and Hepatology, 18(7), 1493-1500. ELSEVIER SCIENCE INC
Clinical Gastroenterology and Hepatology, 18, 7, pp. 1493-1500
Clinical gastroenterology and hepatology, 18(7), 1493-1500. W.B. Saunders Ltd
Clinical Gastroenterology and Hepatology, 18, 1493-1500
Clinical Gastroenterology and Hepatology, 18(7), 1493-1500. ELSEVIER SCIENCE INC
Clinical Gastroenterology and Hepatology, 18, 7, pp. 1493-1500
Contains fulltext : 220797pub.pdf (Publisher’s version ) (Open Access) BACKGROUND & AIMS: We evaluated the incidence of interval cancers between the first and second rounds of colorectal cancer (CRC) screening with the FOB-Gold fecal immunochemical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b017313265cd95870ad87d6340feec58
https://pure.eur.nl/en/publications/04087563-cc46-40d9-8d37-54d5598cb1b9
https://pure.eur.nl/en/publications/04087563-cc46-40d9-8d37-54d5598cb1b9
Autor:
Lawrence Paszat, Jean H E Yong, Linda Rabeneck, Frank van Hees, Simon L. Goede, Marjolein van Ballegooijen, Jeffrey S Hoch, Ann G. Zauber, Jill Tinmouth, Iris Lansdorp-Vogelaar
Publikováno v:
International Journal of Cancer. 137:1119-1127
textabstractIn the province-wide colorectal cancer (CRC) screening program in Ontario, Canada, individuals with a family history of CRC are offered colonoscopy screening and those without are offered guaiac fecal occult blood testing (gFOBT, Hemoccul
Autor:
Virginie G. Daguisé, Iris Lansdorp-Vogelaar, Franklin G. Berger, Alex van der Steen, Marjolein van Ballegooijen, Gailya P Walter, Amy B. Knudsen, Frank van Hees, Ann G. Zauber, Karen M. Kuntz
Publikováno v:
Health Services Research, 50(3), 768-789. Wiley-Blackwell Publishing Ltd
Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. Each year almost 150,000 new CRC cases are diagnosed and more than 50,000 people die from the disease (Siegel, Naishadham, and Jemal 2013). Several randomized c
Autor:
Florence K. L. Tangka, Marjolein van Ballegooijen, Iris Lansdorp-Vogelaar, Amy B. Knudsen, Karen M. Kuntz, Simon L. Goede, Ann G. Zauber, Joseph Chin, David Howard, Laura C. Seeff
Publikováno v:
Medical Care, 53(7), 630-638. Lippincott Williams & Wilkins
Background:Many individuals have not received recommended colorectal cancer (CRC) screening before they become Medicare eligible at the age of 65. We aimed to estimate the long-term implications of increased CRC screening in the pre-Medicare populati
Autor:
Monique E. van Leerdam, Esther M. Stoop, Ernst J. Kuipers, Evelien Dekker, Roderik A. Kraaijenhagen, Thomas R. de Wijkerslooth, Inge Stegeman, Marjolein van Ballegooijen, Paul Fockens, Patrick M.M. Bossuyt
Publikováno v:
Cancer Epidemiology, 37(3), 278-283. Elsevier
Cancer epidemiology, 37(3), 278-283. Elsevier BV
Cancer epidemiology, 37(3), 278-283. Elsevier BV
Several risk factors for colorectal cancer (CRC) have been identified. If individuals with risk factors are more likely to harbor cancer or it precursors screening programs should be targeted toward this population. We evaluated the predictive value
Autor:
Suzette M. Matthijsse, Kirsten Rozemeijer, Steffie K. Naber, Inge M.C.M. de Kok, Corine Penning, Marjolein van Ballegooijen
Publikováno v:
PLoS One (print), 11(1). Public Library of Science
PLoS ONE, Vol 11, Iss 1, p e0145548 (2016)
PLoS ONE
PLoS ONE, Vol 11, Iss 1, p e0145548 (2016)
PLoS ONE
Background Vaccination against the oncogenic human papillomavirus (HPV) types 16 and 18 will reduce the prevalence of these types, thereby also reducing cervical cancer risk in unvaccinated women. This (measurable) herd effect will be limited at firs
Autor:
Caspar W. N. Looman, Aafke H. van Roon, Jacqueline C. Reijerink, Monique E. van Leerdam, Ernst J. Kuipers, Hans 't Mannetje, S. Luuk Goede, J. Dik F. Habbema, Katharina Biermann, Marjolein van Ballegooijen, Alexandra C M van der Togt, Anneke J van Vuuren
Publikováno v:
Gut, 62(3), 409-415. BMJ Publishing Group
Objective Colorectal cancer screening by means of faecal immunochemical tests (FITs) requires successive screening rounds for an optimal preventive effect. However, data on the influence of the length of the screening interval on participation and di